- Home
- HUIZ vs ALLR Comparison
HUIZ vs ALLR Comparison
Compare HUIZ & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUIZ | ALLR |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 19.3M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HUIZ | ALLR |
|---|---|---|
| Price | $1.72 | $1.24 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.30 | ★ $9.75 |
| AVG Volume (30 Days) | 99.2K | ★ 109.7K |
| Earning Date | 03-27-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $320,000.00 |
| Revenue This Year | $8.58 | N/A |
| Revenue Next Year | $6.64 | N/A |
| P/E Ratio | $7.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.19 | $0.77 |
| 52 Week High | $4.16 | $2.35 |
Technical Indicators
Market Signals| Indicator | HUIZ | ALLR |
|---|---|---|
| Relative Strength Index (RSI) | 51.29 | 57.19 |
| Support Level | $1.60 | $0.98 |
| Resistance Level | $2.12 | $1.24 |
| Average True Range (ATR) | 0.18 | 0.07 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 87.39 | 78.60 |
Price Performance
Historical ComparisonAbout HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.